Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Buburuza Unveils AI-Native Payment Platform That Automates Global Money Movement
-
Northwest Indian College Becomes First Tribal College to Deploy Both Beam Global’s BeamBike™ and EV ARC™ Systems
-
Datavault AI Appoints U.S. Navy Veteran Pete Scobell as Vice President, Global Security
-
Special meeting of MEG shareholders to vote on Cenovus transaction postponed to Thursday, October 30, 2025
-
Mitsui & Co., Ltd. Invests in Kite Mobility to Accelerate Shared Electric Mobility in Canada and Beyond
-
Everything Blockchain (OTC: EBZT) CEO Backs Company with Proposed $300K Personal Credit Line; Major Shareholder Cancels 3.5M Shares to Strengthen Value
-
Collège Boréal launches three micro-credentials to strengthen leadership in early childhood management
-
Vital yet vulnerable: Expert panel report examines security risk and resilience in Canada’s research enterprise
-
MBOLD Launches ‘Protein Catalyst’ to Drive Animal & Plant Protein Innovation in Rapidly Growing Global Protein Industry
-
Sophos Announces Latest Evolution of Its Security Operations Portfolio
-
Sophos Launches ITDR to Protect Against Growing Identity-Based Attacks
-
MEXC Launches ENA Extravaganza with $1 Million Prize Pool, Zero-Fee Trading and Up to 600% APR Staking
-
Ambow Education Reports 2025 Strategic Progress and Expanding Global Adoption of HybriU™ Technology
-
First Atlantic Nickel Announces Expanded 4-Kilometer Strike Length at RPM Zone from DTR Surface Sampling at Pipestone XL Nickel Alloy Project
-
OMS Energy Technologies Inc. Expands Sustainable Wellhead Refurbishment Program
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Mr. Cooper Group Inc. (NASDAQ: COOP) Investors Who Received Rocket Companies, Inc. (NYSE: RKT) Shares in Connection with Rocket’s Acqui
-
Everything Blockchain (OTC: EBZT) CEO Backs Company with Proposed $300K Personal Credit Line; Major Shareholder Cancels 3.5M Shares to Strengthen Value
-
RadNet to Host Investor Day on November 11, 2025
-
MBOLD Launches ‘Protein Catalyst’ to Drive Animal & Plant Protein Innovation in Rapidly Growing Global Protein Industry
-
Credit Unions to Ottawa: Modernize Financial Rules to Strengthen Competition and Expand Consumer Choice
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
First Mold to Integrate AI Agents in CNC Machining Management
-
High Tide Resources Provides Update on the Labrador West Iron Ore Project
-
BlackRock® Canada Announces October Cash Distributions for the iShares® ETFs
-
iQIYI to Report Third Quarter 2025 Financial Results on November 18, 2025
-
Mowi’s acquisition of Nova Sea approved
-
Fortescue Announces Early Tender Results of Cash Tender Offers for Certain of Its Debt Securities
-
Same Day Loan Guaranteed Approval: RadCred Offers Urgent Loans for Bad Credit Guaranteed Approval with Instant Matching
-
VEON’s Beeline Kazakhstan to Acquire Online Classifieds Business OLX Kazakhstan
-
InterDigital renews license agreement with Sharp and signs new IoT license
-
VEON’s Beeline Kazakhstan to Acquire Online Classifieds Business OLX Kazakhstan
-
The 67th (Autumn 2025) Pharmaceutical Machinery Exposition Concludes Successfully
-
PrestoDoctor Expands Into Michigan Ahead of New Cannabis Tax Changes
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
Form 8.5 (EPT/RI)-Dowlais Group plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Form 8.5 (EPT/RI)- NCC Group plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
Form 8.5 (EPT/RI)-Treatt plc
-
Form 8.5 (EPT/RI)-PRS Reit PLC
-
Innovation·Defining the Future: JETOUR JMA Global Media Alliance Tech Tour Kicks Off
-
selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease
-
selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
CECOCECO Brings First Curved ArtMorph Installation to Workspace Design Show Amsterdam 2025
-
Appian and IFC partner to launch new US$1 billion critical minerals and metals fund for emerging markets
-
Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
-
Acies Bio doubling biomanufacturing capacity with the construction of 30 m³ bioreactor
-
SiriusPoint Announces Will Nihan as IMG CEO
